Company / EPS (Diluted)
HERON THERAPEUTICS, INC. /DE/ EPS (Diluted) History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.95
FY2017
5-year range
-$2.95 / -$2.87
FY2016-FY2017
Trend
-2.8%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-2.95 in FY2017.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, eps (diluted) decreased 2.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$2.95 | -2.8% |
| FY2016 | -$2.87 | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026